Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent

First Page		Document Content
		Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent Add to Reading List Source URL: www.translational-medicine.com Download Document from Source Website File Size: 684,95 KB Share Document on Facebook